Add office photos
Engaged Employer
SAI Life Sciences
3.9
based on 1k Reviews
Company Overview
Company Locations
Working at SAI Life Sciences
Company Summary
Overall Rating
3.9/5
based on 1k reviews
3% above
industry average
Highly rated for
Skill Development, Salary & Benefits
Critically rated for
Promotions/Appraisal
Work Policy
Work from office
81% employees reported
Monday to Friday
44% employees reported
Flexible timing
55% employees reported
No travel
48% employees reported
View detailed work policy
Top Employees Benefits
Office cab/shuttle
95 employees reported
Job/Soft skill training
72 employees reported
Cafeteria
58 employees reported
Health insurance
40 employees reported
View all benefits
About SAI Life Sciences
Founded in1999 (25 yrs old)
India Employee Count1k-5k
Global Employee Count1k-5k
India HeadquartersHyderabad, India
Office Locations
Websitesailife.com
Primary Industry
Other Industries
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.
Mission: Sai provides services to our pharma innovator partners, which accelerate discovery, development and manufacture of complex small molecules. Sai commits to being reliable, fully compliant and continuously get better at every aspect of our service.
Vision: Sai Life Sciences will facilitate launch of 25 new medicines by our global innovator partners through 2025 and achieve $250 million in annual revenue. For our employees, we will cultivate a stimulating work environment and become one of the top 3 CDMO’s to work for by 2020. Our actions are guided by a culture of integrity and respect while embracing our social responsibility.
Report error
SAI Life Sciences Ratings
based on 1k reviews
Overall Rating
3.9/5
How AmbitionBox ratings work?
5
404
4
348
3
134
2
66
1
85
Category Ratings
3.9
Skill Development
3.8
Salary & Benefits
3.7
Company Culture
3.7
Work-Life Balance
3.6
Work Satisfaction
3.5
Job Security
3.3
Promotions/Appraisal
SAI Life Sciences is rated 3.9 out of 5 stars on AmbitionBox, based on 1k company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at SAI Life Sciences
based on 1k reviews
3.9
Rated by 108 Women
Rated 3.7 for Skill Development and 3.7 for Company Culture
3.9
Rated by 900 Men
Rated 3.9 for Salary & Benefits and 3.9 for Skill Development
Work Policy at SAI Life Sciences
based on 110 reviews in last 6 months
Work from office
81%
Hybrid
17%
Permanent work from home
2%
SAI Life Sciences Reviews
Top mentions in SAI Life Sciences Reviews
+ 5 more
Compare SAI Life Sciences with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.9/5 based on 1k reviews | 3.9/5 based on 1.8k reviews | 3.8/5 based on 1.3k reviews | 3.9/5 based on 1.1k reviews |
Highly Rated for | Skill development Salary & Benefits | Job Security Company culture Work-Life balance | Job Security | Skill development Work-Life balance Company culture |
Critically Rated for | Promotion/Appraisals | Promotion/Appraisals | Work Satisfaction Promotion/Appraisals Company culture | No critically rated category |
Primary Work Policy | Work from office 81% employees reported | Work from office 89% employees reported | Work from office 93% employees reported | Work from office 84% employees reported |
Rating by Women Employees | 3.9 Good rated by 108 women | 3.8 Good rated by 337 women | 4.0 Good rated by 145 women | 3.6 Good rated by 89 women |
Rating by Men Employees | 3.9 Good rated by 900 men | 4.0 Good rated by 1.4k men | 3.8 Good rated by 1.1k men | 3.9 Good rated by 942 men |
Job Security | 3.5 Good | 4.1 Good | 4.0 Good | 3.8 Good |
View more
SAI Life Sciences Salaries
3.8
rated by 1k employees for salariesResearch Chemist
(318 salaries)
Unlock
₹2.5 L/yr - ₹6 L/yr
Executive Production
(225 salaries)
Unlock
₹2.4 L/yr - ₹5 L/yr
Research Associate
(207 salaries)
Unlock
₹2.7 L/yr - ₹9.8 L/yr
Senior Research Associate
(169 salaries)
Unlock
₹4.5 L/yr - ₹13.4 L/yr
Associate Research Scientist
(159 salaries)
Unlock
₹6.1 L/yr - ₹15 L/yr
Senior Research Chemist
(147 salaries)
Unlock
₹3.6 L/yr - ₹7.9 L/yr
Deputy Manager
(121 salaries)
Unlock
₹7 L/yr - ₹16.1 L/yr
Research Scientist
(90 salaries)
Unlock
₹6.2 L/yr - ₹14.8 L/yr
Research Assistant
(65 salaries)
Unlock
₹2.4 L/yr - ₹6.5 L/yr
Process Engineer
(43 salaries)
Unlock
₹3 L/yr - ₹7 L/yr
SAI Life Sciences Interview Questions
Interview questions by designation
Top SAI Life Sciences interview questions and answers
Get interview-ready with top interview questions
Interview Process at SAI Life Sciences
based on 17 interviews in last 1 year
Interview Experience
4.5
Good
Difficulty level
Easy
16%
Moderate
69%
Hard
15%
People are getting interviews through
based on 54 SAI Life Sciences interviews
Walkin
30%
Referral
19%
Job Portal
19%
Company Website
7%
*25% candidates got the interview through other sources
High confidence
SAI Life Sciences Jobs
SAI Life Sciences News
View all
Sai Life Sciences Shares End At 40% Premium Over Issue Price
- The share price of Sai Life Sciences Ltd. ended at Rs 768.4 apiece, a premium of 39.9% over the issue price of Rs 549 apiece.
- The IPO was subscribed 10.26 times on its final day, with qualified institutional buyers leading the bids.
- Sai Life Sciences is a contract research, development, and manufacturing organization catering to global pharmaceutical and biotechnology companies.
- The IPO proceeds will be used for debt payment and corporate general purposes.
Bloomberg Quint | 18 Dec, 2024
TPG Capital-backed Sai Life Sciences to list today
- Sai Life Sciences, backed by TPG Capital, is set to list today.
- Promoter entity Sai Quest Syn Private Ltd, along with TPG Asia VII SF Pte Ltd and HBM Private Equity India, will divest part of their stakes through an offer for sale (OFS) process.
- The qualified institutional buyer (QIB) portion of the IPO was subscribed 30.93 times, while the retail investor and high net worth individual (HNI) quota were subscribed 1.37 times and 4.92 times, respectively.
- The IPO proceeds will be used for debt repayment and general corporate purposes, with ₹600 crore allocated for debt repayment.
HinduBusinessLine | 18 Dec, 2024
Sai Life Sciences Shares Debut At 19% Premium Over Issue Price
- The share price of Sai Life Sciences Ltd. listed on the BSE and NSE at a premium of 20.2% and 18.4% respectively over the issue price.
- The Sai Life Sciences IPO was subscribed 10.26 times on its final day, with qualified institutional buyers leading the bids.
- The IPO included a fresh issue of 1.73 crore shares worth Rs 950 crore and an offer for sale of 3.81 crore shares.
- Sai Life Sciences is an innovator-focused contract research and manufacturing organization, offering comprehensive services across the drug discovery and development value chain.
Bloomberg Quint | 18 Dec, 2024
Premium Or Discount Listing? What GMP Of Vishal Mega Mart, Mobikwik And Sai Life Sciences IPOs Suggests
- The IPOs of Vishal Mega Mart, Mobikwik, and Sai Life Sciences have closed for subscription and are set to list on the BSE and NSE on Dec. 18.
- Investors can check the grey market premium (GMP) for a rough estimate of the possible listing price.
- Vishal Mega Mart IPO has a GMP of Rs 20.50 with a projected listing gain of 26.28%.
- MobiKwik IPO has a GMP of Rs 165 with a projected listing gain of 59.14%.
Bloomberg Quint | 17 Dec, 2024
Check Sai Life Sciences IPO GMP Ahead Of Share Allotment Today; Find Steps To Verify Status
- The grey market premium of the Sai Life Sciences IPO was Rs 50 as of 5:03 am on December 16.
- Investors who bid in Sai Life Sciences IPO now await the finalisation of the share allotment status.
- Sai Life Sciences IPO share allotment will be finalised on December 16 following a successful three-day bidding period.
- Investors can check the share allotment status on BSE, NSE, and KFin Technologies Ltd's websites.
Bloomberg Quint | 16 Dec, 2024
Sai Life Sciences issue garners bids for 10.26 times
- Sai Life Sciences issue garnered bids for 10.26 times in the Offer For Sale (OFS).
- The QIB portion was subscribed 30.93 times, while retail and HNI quotas were subscribed 1.37 times and 4.92 times respectively.
- The company raised ₹913 crore from anchor investors as part of the IPO process, allocating equity shares to 63 funds.
- The IPO proceeds will be used for debt repayment and general corporate purposes.
HinduBusinessLine | 13 Dec, 2024
Sai Life Sciences IPO Subscribed 1.65 Times So Far On Final Day
- The Sai Life Sciences IPO has been subscribed 1.65 times on the final day.
- The company aims to raise Rs 3,042 crore via the IPO.
- The IPO includes a fresh issue of 1.73 crore shares worth Rs 950 crore and an offer for sale of 3.81 crore shares totalling Rs 2,092.6 crore.
- The funds raised will be utilized for debt repayment and general corporate purposes.
Bloomberg Quint | 13 Dec, 2024
Sai Life Sciences IPO closes today
- The initial public offering (IPO) of Sai Life Sciences, an integrated contract research, development, and manufacturing organization (CRDMO), is set to close today.
- The IPO includes an offer for sale (OFS) by promoter entities and investor shareholders, with the retail quota at 35%, the QIB portion at 50%, and the NII category at 15% of the total.
- The QIB portion was subscribed 3.32 times, while the retail and NII portions were undersubscribed at 0.42 times and 0.59 times respectively.
- Of the IPO proceeds, ₹600 crore will be allocated for debt repayment, and the rest for general corporate purposes.
HinduBusinessLine | 13 Dec, 2024
Sai Life Sciences' IPO subscribed 1.25X on Day 2 of bidding
- The IPO of Sai Life Sciences Ltd got subscribed 1.25 times on Day 2 of bidding.
- The IPO received bids for 4,86,23,247 shares against 3,88,29,848 shares on offer.
- The QIB quota received 3.32X subscriptions, non-institutional investors portion subscribed 59%, and retail investors portion subscribed 42%.
- The IPO, priced between Rs 522-549 apiece, will conclude on Friday.
Yourstory | 12 Dec, 2024
Sai Life Sciences IPO Subscribed 89% On Day 2
- Sai Life Sciences IPO subscribed 89% on Day 2
- The IPO includes a fresh issue of 1.73 crore shares worth Rs 950 crore and an offer for sale of 3.81 crore shares totalling Rs 2,092.6 crore.
- The company raised Rs 912.7 crore from anchor investors.
- The funds raised will be utilized for debt repayment and general corporate purposes.
Bloomberg Quint | 12 Dec, 2024
Powered by
SAI Life Sciences Offices
Compare SAI Life Sciences with
DRJ & CO
5.0
Biocon Limited
3.9
Glenmark Pharmaceuticals
4.0
Strides Pharma
4.0
Lupin
4.2
Cipla
4.1
Sun Pharmaceutical Industries
4.1
IQVIA
3.9
Aragen Life Sciences
4.1
Parexel International
4.0
Qinecsa Solutions
2.9
Fortrea Development India Private Limited
4.0
ICON Plc
4.2
Lambda Therapeutic Research
4.6
Reliance Life Sciences
3.6
Aizant Drug Research Solutions
3.9
Veeda Clinical Research
3.9
Apcer Life Sciences
3.6
Rubicon Research
3.4
Cliantha Research
4.0
Contribute & help others!
You can choose to be anonymous
Companies Similar to SAI Life Sciences
Syngene International
Clinical Research
3.9
• 1.8k reviews
Piramal Group
Pharma
3.9
• 1.1k reviews
DIVI'S Laboratories
Pharma
3.8
• 1.3k reviews
DRJ & CO
Architecture & Interior Design
5.0
• 1 reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.8k reviews
Glenmark Pharmaceuticals
Pharma
4.0
• 2.7k reviews
Strides Pharma
Pharma
4.0
• 862 reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 5.8k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.5k reviews
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.1
• 5.5k reviews
IQVIA
Consulting, Healthcare / Pharma, Internet, Analytics & KPO, Clinical Research, Healthcare, Pharma
3.9
• 3.9k reviews
Aragen Life Sciences
Biotech & Life sciences, Analytics & KPO, Clinical Research
4.1
• 1.4k reviews
SAI Life Sciences FAQs
When was SAI Life Sciences founded?
Where is the SAI Life Sciences headquarters located?
How many employees does SAI Life Sciences have in India?
Does SAI Life Sciences have good work-life balance?
Is SAI Life Sciences good for career growth?
What are the pros and cons of working in SAI Life Sciences?
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
